(Q37820525)

English

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

scientific article published on December 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

Michael Camilleri

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23 August 2017

Michael Camilleri

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

publication date

1 December 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

published in

IDrugs: the Investigational Drugs Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

page(s)

921-928

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Identifiers

PubMed publication ID

21154152

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21154152

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21154152%20AND%20SRC:MED&resulttype=core&format=json

(Q37820525)

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)